• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

MYL:US

51.9000 USD 0.4400 0.84%

As of 20:10:00 ET on 07/24/2014.

Snapshot for Mylan Inc/PA (MYL)

Open: 52.6400 Day's Range: 51.8800 - 52.9000 Volume: 3,013,512
Previous Close: 52.3400 52wk Range: 32.0000 - 57.5200 1-Yr Rtn: +59.25%

Stock Chart for MYL

No chart data available.
  • MYL:US 51.9250
  • 1D
  • 1M
  • 1Y
52.3400
Interactive MYL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYL

Current P/E Ratio (ttm) 25.6582
Estimated P/E(12/2014) 15.3732
Relative P/E vs. SPX 1.4097
Earnings Per Share (USD) (ttm) 2.0227
Est. EPS (USD) (12/2014) 3.3760
Est. PEG Ratio 1.3052
Market Cap (M USD) 19,396.65
Shares Outstanding (M) 373.73
30 Day Average Volume 4,109,088
Price/Book (mrq) 6.1062
Price/Sale (ttm) 2.8059
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 07/17/2007
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYL

Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.

Robert J CouryChairmanRodney L PiattVice Chairman
Heather BreschChief Executive OfficerRajiv MalikPresident
More Company Profile & Key Executives for MYL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil